Bio
Avik Roy is author of the influential Forbes health-policy blog, The Apothecary, and a Senior Fellow at the Manhattan Institute for Policy Research. He writes on health care, entitlement reform, finance, and other policy issues for Forbes, National Review, National Affairs, and other publications.
Professionally, he works as a healthcare analyst at Monness, Crespi, Hardt & Co. in New York City. Prior to his current position, he worked as an analyst and portfolio manager at J.P. Morgan, Bain Capital, and other firms.
To contact him, click here.
Re: National Review: Anyone But Newt
I would switch out Santorum in favor of Perry, but overall, I'm puzzled by the anti-NR outcry. Is it really so terrible to try to winnow the field? Far from it -- we need to winnow the field and focus on the people who would plausibly make good presidents. We might disagree as to how that field should be narrowed, but NR has a right to its opinion.
As to Gingrich, my view is that he would be a catastrophic mistake.